Search

Josh M Morganti

from Indian Harbour Beach, FL
Age ~41
Get Report
Also known as:
Joshua M Morganti, Josh I
Related to:
Denise A Donovan, 64Dominick A Morganti, 44George Doty, 60Sherrie Brumfield, 53Mark Smith, 66
Connected to:
Angela F Morganthal, 39Belinda Morgantini, 46Carlo Morgantini, 53Christina M Morganti, 32Gary R Morganthal, 42John D Morgantini, 55Justin Morganti, 46Larry MorgantiLaurie A Morgante, 62Lindsey N Morganti, 41

Josh Morganti Phones & Addresses

  • Indian Harbour Beach, FL
  • Lexington, KY
  • Palm Harbor, FL
  • Richmond, CA
  • San Francisco, CA
  • Tampa, FL
  • Frankfort, KY
  • Deland, FL
  • Harrodsburg, KY
  • 64 Shoreline Ct, Richmond, CA 94804 (386) 734-0826

Work

Company: Ucsf Dec 2011 to Jun 2016 Position: Nih postdoctoral fellow

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of South Florida 2008 to 2011 Specialities: Philosophy, Neuroscience

Industries

Higher Education

Resumes

Resumes

Josh Morganti Photo 1

Assistant Professor

Location:
4117 Clearwater Way, Lexington, KY 40515
Industry:
Higher Education
Work:
Ucsf Dec 2011 - Jun 2016
Nih Postdoctoral Fellow
University of Kentucky Dec 2011 - Jun 2016
Assistant Professor
University of South Florida Aug 2008 - Dec 2011
Graduate Research Assistant
Education:
University of South Florida 2008 - 2011
Doctorates, Doctor of Philosophy, Philosophy, Neuroscience University of South Florida 2007 - 2008
Masters, Pharmacology Stetson University 2003 - 2007
Bachelors, Bachelor of Science, Biology

Publications

Us Patents

Recombinant Adeno-Associated Virus-Mediated Expression Of Fractalkine For Treatment Of Neuroinflammatory And Neurodegenerative Diseases

US Patent:
20140205570, Jul 24, 2014
Filed:
Jun 30, 2012
Appl. No.:
14/126708
Inventors:
Carmelina Gemma - Tampa FL, US
Paula C. Bickford - Ruskin FL, US
Kevin R. Nash - Tampa FL, US
Josh Morganti - Tampa FL, US
Adam Bachstetter - Lexington KY, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
C07K 14/52
US Classification:
424 932, 435456, 4353201
Abstract:
The subject invention pertains to the use of fractalkine (FKN, CX3CL1) and its receptor CX3CR1 for treatment of neuroinflammation and/or neurodegeneration. In one embodiment, the present invention provides a method for treatment of neuroinflammation and/or neurodegenerative diseases, comprising: administering, to cells of a subject in need of such treatment, an adeno-associated virus that comprises a functional fractalkine gene operably linked to transcriptional control elements. In one embodiment, the subject invention is used to treat or ameliorate Parkinson's disease. The present invention can also be used to treat or ameliorate neuroinflammatory and/or neurodegenerative diseases including, but not limited to, Alzheimer's disease, epilepsy, aging, and traumatic brain injury.
Control profile
Josh M Morganti from Indian Harbour Beach, FL, age ~41 Get Report